BioMed Research International
Volume 2016 (2016), Article ID 4874809, 11 pages
http://dx.doi.org/10.1155/2016/4874809

Research Article

Vitamin A Inhibits Development of Dextran Sulfate Sodium-Induced Colitis and Colon Cancer in a Mouse Model

Isao Okayasu,¹ Kiyomi Hana,¹ Noriko Nemoto,² Tsutomu Yoshida,¹ Makoto Saegusa,¹ Aya Yokota-Nakatsuma,³ Si-Young Song,⁴ and Makoto Iwata³

¹Department of Pathology, School of Medicine, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan
²Research Center for Biological Imaging, School of Medicine, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan
³Laboratory of Immunology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki, Kagawa 769-2193, Japan
⁴Institute of Neuroscience, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki, Kagawa 769-2193, Japan

Received 25 January 2016; Revised 30 March 2016; Accepted 12 April 2016

Academic Editor: Andrea Vecchione

Copyright © 2016 Isao Okayasu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Vitamin A is essential to mucosal immunity and cell differentiation. The fact that lack of it might involve chronic inflammation and increased risk of cancer has been reported. Little is known about the mechanism of vitamin A deficiency in the development of colitis and its influence on development of colorectal cancer. To determine the influence of vitamin A deficiency on colitis and colorectal cancer development, an experimental study using a colitis mouse model was performed. Dextran sulfate sodium (DSS) colitis was induced in vitamin A-deficient and vitamin A-supplemented mice. Further, colorectal carcinoma was induced by a combination of azoxymethane preinjection and DSS colitis. Results were compared between the two groups mainly by immunohistochemical analysis. Colitis was more severe and recovery from colitis was slower in vitamin A-deficient mice than in vitamin A-supplemented mice. Compared with vitamin A-supplemented mice, vitamin A-deficient mice had decreases in colonic subepithelial myofibroblasts and the ratio of mucosal IgA⁺/IgG⁺ cells, increases in CD11c⁺ dendritic cells, and a higher rate of development of colorectal carcinoma with colitis following azoxymethane. Vitamin A lipid droplets in subepithelial myofibroblasts were decreased in vitamin A-deficient mice, suggesting alterations in colonic crypt niche function. Thus, vitamin A inhibited colitis and the development of colorectal cancer.

1. Introduction

The influence of vitamin A and its deficiency on mucosal immunity and cell differentiation has been widely explored and lack of it has been reported to involve chronic inflammation and increased risk of cancer. Through a retrospective chart review it was revealed that deficiencies of vitamins D and A and zinc were relatively common in children and young adults with newly developed inflammatory bowel diseases [1]. Also, low levels of serum vitamins A and E were shown in children and young adults with active inflammatory bowel disease [2].

Further, vitamin A deficiency enhanced the T-helper type 1 (Th1) response and elevated levels of proinflammatory cytokines in obese individuals, suggesting an increased inflammatory response [3]. In rats with vitamin A deficiency downregulation of Retinoic Acid Receptor- (RAR-) α mRNA, increased dendritic cells, and increased protein secretion of IL-12 in the intestinal mucosa were shown. Inversely, supplemental vitamin A in an in vitro culture system of Peyer’s patches promoted maturation of dendritic cells and upregulation of RAR-α mRNA, suggesting the possibility of a reduction in intestinal inflammation [4]. Kang et al. reported that a high vitamin A level induced a CCR9⁺  α4β7⁺ FoxP3⁺ T cell subset, suppressive of intestinal inflammation in SAMP1/YP mice, which had the characteristic of developing spontaneous transmural ileitis like Crohn’s disease [5]. These findings suggest that vitamin A is important in maintaining appropriate mucosal immunity and in regulating intestinal inflammation. Considering the above findings, there may be an association of vitamin A levels with intestinal inflammation.

Retinoids, vitamin A metabolites, are essential for epithelial differentiation and control of epithelial and mesenchymal interaction through Ret expression [6]. Concerning carcinogenesis, retinoids are effective in chemoprevention and differentiation therapy for cancers of various organs [7]. Further, an association of vitamin A deficiency with cervical intraepithelial neoplasia in HIV-infected women was reported [8] as was chemically induced nephroblastoma in rats [9]. CYP26A1, the gene encoding the cytochrome P450 enzyme which is a major retinoic acid-catabolic enzyme, was highly expressed in cancers of various organs [10–13]. Decreased intracellular retinoic acid or a deficiency due to high CYP26A1 expression induced cells into highly proliferative and invasive states [13] and promoted significant resistance to apoptosis, possibly contributing to the carcinogenic process [14]. These findings may indicate that vitamin A deficiency promotes carcinogenesis [15]. Regarding nutrition, inverse associations were shown between the risk of colon cancer and the use of multivitamin and calcium supplements, although direct associations between colon cancer risk and supplemental vitamin A and vitamin C were inconsistent [16].

Previously we revealed that subepithelial myofibroblasts corresponded to colonic stellate cells containing vitamin A lipid droplets, which are thought to play an important role in the maintenance of the niche function of colonic stem cells [17–20]. For this report, we examined whether vitamin A inhibits intestinal inflammation and the development of inflammation-associated colon cancer using our previously developed DSS colitis mouse model [21, 22].

2. Materials and Methods

2.1. Mice

BALB/c mice were purchased from CLEA Japan (Tokyo, Japan) and maintained under specific pathogen-free conditions in our animal center. Vitamin A-deficient and vitamin A-supplemented BALB/c female mice were produced according to a previously described method [23, 24]. Briefly, mice were bred, and gravid females received either a chemically defined diet that lacked vitamin A (modified AIN-93M feed, Oriental Yeast, Tokyo, Japan) or a vitamin A-supplemented control diet containing retinyl acetate (5,000 IU/kg in the modified AIN-93M feed). This concentration is appropriate as a supplement considering the natural oxidative degradation of vitamin A [24, 25]. These diets were started before gestation. The mouse pups were weaned at 4 weeks of age and maintained on the same diet until the experiment finished.

2.2. Induction and Assessment of Colitis

Colitis was induced with administration of synthetic dextran sulfate sodium (DSS, mol wt 54,000, Ensuikou Sugar Refining Co., Ltd., Chuo-ku, Tokyo, Japan), a procedure that we originally developed [21]. Briefly, mice were divided into two groups, vitamin A-deficient and vitamin A-supplemented groups, and given distilled drinking water containing 0% or 1% (wt/vol) DSS ad libitum under the regimen established for the experiment. After drinking 0% or 1% DSS for 7 or 12 days, mice were killed. The removed colon was put on thick qualitative filter paper, exposed inside out by cutting longitudinally, and fixed in 10% formalin solution. Longitude of each colon was measured. Histological examinations were performed with H&E staining of paraffin sections of the longitudinal sections of the colons [21]. Total colon was equally divided into three segments, the proximal, middle, and distal segments, to assess the distribution of colitis. Severity of colitis at each part was graded on a scale from 0 to 3 and expressed as the pathological index according to the standard scoring system: 0, normal; 1, focal inflammatory cell infiltration including polymorphonuclear leukocytes; 2, inflammatory cell infiltration with gland dropout and/or crypt abscess; and 3, mucosal ulceration. The sum of each colitis score at three segments was shown as total colitis score.

2.3. Induction of Colonic Tumors

For induction of colonic tumors, mice were administered an intraperitoneal injection of azoxymethane (7.4 mg/kg, Sigma-Aldrich Corp., St. Louis, MO, USA), which was followed beginning two weeks later by administration of 1% DSS for 7 days. After drinking distilled water for 3 weeks, the mice were killed. All polypoid or flat elevated lesions that developed were histopathologically counted by observation of a longitudinal paraffin section with H&E staining [22].

2.4. Electron Microscopic Examination

For electron microscopic observation, the colonic wall was fixed by 2.5% (vol/vol) glutaraldehyde in a solution of phosphate buffer (pH 7.2) and by 2% (wt/vol) osmium tetroxide in a similar phosphate buffer solution (pH 7.2). After Epon embedding, ultrathin sections were stained with uranyl acetate and lead citrate followed by electron microscopic examination.

2.5. Immunohistochemical Analysis

Immunohistochemical staining was performed as shown in Table 1. Frozen sections of colonic mucosa after 2% paraformaldehyde fixation were supplied for examination of CD11c⁺ dendritic cells. Formalin-fixed paraffin sections were used for analysis of α-SMA⁺, IgM⁺, IgG⁺, and IgA⁺ cells. Sections were incubated with the primary antibodies at the given dilution overnight at 4°C. 3,3′-Diaminobenzidine was applied as the final chromogen, and nuclei were counterstained with methyl green solution to facilitate histopathological assessment.

Table 1: Antibodies and immunohistochemical examination.

Antibody
Clone
Source
Fixation
Dilution
Antigen retrieval
2nd step and colorization
Interpretation

CD11c
Hamster anti-mouse CD11c
BD Pharmingen 550283
2% paraformaldehyde, frozen sections
×10
Not applied
Streptavidin Biotin/HRP kit (Jackson ImmunoResearch, West Grove, PA)
Dendritic cells

-SMA
Monoclonal mouse anti-α-SMA
DAKO M851 (DakoCytomation, Glostrup, Denmark)
10% buffered formalin, paraffin sections
×1000
Not applied
Histofine mouse staining kit (Nichirei, Tokyo, Japan)
Smooth muscle actin

IgM
Goat polyclonal
Abcam ab98673 (Abcam, Cambridge, MA)
10% buffered formalin, paraffin sections
×500
Microwave
5 min
× 3 times
Streptavidin Biotin/HRP kit (Jackson ImmunoResearch)
IgM⁺ lymphocytes

IgG
Goat polyclonal
Abcam ab98802 (Abcam, Cambridge, MA)
10% buffered formalin, paraffin sections
×500
Microwave
5 min
× 3 times
Streptavidin Biotin/HRP kit (Jackson ImmunoResearch)
IgG⁺ lymphocytes

IgA
Goat polyclonal
Abcam ab97233 (Abcam, Cambridge, MA)
10% buffered formalin, paraffin sections
×500
Microwave
5 min
× 3 times
Streptavidin Biotin/HRP kit (Jackson ImmunoResearch)
IgA⁺ lymphocytes

α-SMA: α-smooth muscle antigen.

2.6. Statistical Analysis

Results are summarized as means ± standard deviation (SD). Data were statistically analyzed by the Mann-Whitney test and Chi-squared test using Stat View ver. 5.0 for Windows (SAS Institute Inc., Cary, NC, USA). All p values < 0.05 were considered statistically significant.

3. Results

3.1. Modifications of Intestinal Homeostasis in Vitamin A-Deficient Mice

3.1.1. Decrease in Lipid Droplets in Subepithelial Myofibroblasts in Vitamin A-Deficient Mice

Lipid droplets identified by electron microscopy in subepithelial myofibroblasts that were located in crypt bases were significantly decreased () in vitamin A-deficient mice (3 lipid droplets/36 crypts, 8.3%) compared to vitamin A-supplemented mice (34/111, 30.1%) (Figure 1). Representative figures of stellate cell in the liver were shown in a vitamin A-supplemented mouse and a vitamin A-deficient mouse for the reference (see Supplementary Figure  1 in Supplementary Material available online at http://dx.doi.org/10.1155/2016/4874809).

(a)

(b)

Figure 1: (a) Intracellular lipid droplets in mucosal subepithelial myofibroblasts of the distal segment of the colon. No lipid droplets were observed in a subepithelial myofibroblast from the colonic crypt base of a vitamin A-deficient mouse (upper) in contrast to detection of lipid droplets (arrow) in that of a vitamin A-supplemented mouse (lower) as assessed by electron microscopy. (b) Significant difference of intracellular lipid droplets in mucosal subepithelial myofibroblasts at the crypt base between two groups (Chi-squared test).

3.1.2. Increase in CD11c⁺ Dendritic Cells and Decrease in Subepithelial Myofibroblasts and Ratio of Mucosal IgA⁺/IgG⁺ Cells in Vitamin A-Deficient Mice

α-smooth muscle actin-positive (α-SMA⁺) subepithelial myofibroblasts were significantly decreased (Figure 2). On the contrary, CD11c-immunoreactive dendritic cells (CD11c⁺ cells/250 μm of colonic length) in colonic mucosa were significantly increased in vitamin A-deficient mice compared with vitamin A-supplemented mice (Figure 3). The ratio of IgA⁺ cells (/250 μm of colonic length)/IgG⁺ cells (/250 μm of colonic length) in mucosa of the proximal segment was significantly lower in vitamin A-deficient mice than in vitamin A-supplemented mice but not significantly lower in mucosa of the distal segment (Figure 4). IgA⁺ cells were rather less in vitamin A-deficient mice, compared to vitamin A-supplemented mice in both proximal and distal segments, the difference being not significant.

(a)

(b)

Figure 2: (a) Immunohistochemical α-smooth muscle actin (α-SMA)⁺ subepithelial myofibroblasts (brown) in the colonic mucosa (left, vitamin A-supplemented mouse, and right, vitamin A-deficient mouse). (b) Summary of α-SMA⁺ subepithelial myofibroblasts in the colonic mucosa.

(a)

(b)

Figure 3: (a) Immunohistochemical CD11c⁺ dendritic cells (brown) in the colonic mucosa (left, vitamin A-supplemented mouse, and right, vitamin A-deficient mouse). (b) Summary of CD11c⁺ dendritic cells in the colonic mucosa.

(a)

(b)

Figure 4: (a) Immunohistochemical IgA⁺ or IgG⁺ cells (brown) in the colonic mucosa (upper, vitamin A-supplemented mouse, and lower, vitamin A-deficient mouse). (b) Summary of the ratio of IgA⁺/IgG⁺ cells in the mucosa of the proximal (upper left) and distal segments (upper right) and IgA⁺ cells in the mucosa of the proximal (lower left) and distal (lower right) segments.

3.2. Acceleration of Acute Colitis in Vitamin A-Deficient Mice

Acute colitis induced by oral intake of 1% DSS for 7 days was significantly more severe in vitamin A-deficient mice than in vitamin A-supplemented mice as assessed by shortening of colon length and the colitis score (Figure 5) (Supplementary Table  1a).

(a)

(b)

(c)

Figure 5: (a) Gross appearance of acute DSS colitis of the distal segment of the colon in vitamin A-supplemented mice (left) and vitamin A-deficient mice (right). In the latter there were shortening and dilatation of the colon. Colitis was induced with intake of 1% DSS for 7 days. Significant difference of (b) total colon length and (c) total colitis score between vitamin A-supplemented mice and vitamin A-deficient mice.

Colons of vitamin A-deficient mice were shown histologically to have undergone shortening, mild dilatation due to inflammation, gross and inflammatory granulation, and erosion (Figure 6) (Supplementary Figure  2). Differences in the degree of acute colitis induced by intake of 1% DSS for 12 days between vitamin A-deficient and vitamin A-supplemented mice were again confirmed by increased shortening of colon length, histological colitis score, and ulcer length (Figure 6) (Supplementary Table  1b).

(a)

(b)

(c)

Figure 6: Significant difference of (a) total colon length, (b) total colitis score, and (c) total ulcer length between vitamin A-supplemented mice (left) and vitamin A-deficient mice (right). Colitis was induced with intake of 1% DSS for 12 days.

3.3. Slow Recovery from Acute Colitis in Vitamin A-Deficient Mice

Long-term observation of colitis after induction by intake of 1% DSS for 7 days revealed extensive differences between vitamin A-deficient and vitamin A-supplemented mice on experimental day 43. Vitamin A-deficient mice had much more severe colitis, including increased shortening of colon length, increased histological colitis score, and increased total ulcer length compared to vitamin A-supplemented mice (Figure 7) (Supplementary Table  1c). These findings indicate that not only the development of DSS colitis is worse with vitamin A deficiency but also recovery from DSS colitis is much slower.

(a)

(b)

(c)

Figure 7: Recovery from acute colitis. Significant difference of (a) total colon length, (b) total colitis score, and (c) total ulcer length between vitamin A-supplemented mice (left) and vitamin A-deficient mice (right). Colitis was induced with intake of 1% DSS for 7 days. After that, mice were given distilled drinking water for 36 days.

3.4. Development of Colonic Tumors in Vitamin A-Deficient Mice

A single intraperitoneal injection of azoxymethane (7.4 mg/kg) 14 days prior to intake of 1% DSS for 7 subsequent days [7] induced multiple types of colorectal neoplasia, including low grade dysplasia, high grade dysplasia, and invasive carcinoma as well as severe colitis in vitamin A-deficient mice (Figures 8, 9, and 10). In contrast, only a few neoplastic lesions developed in vitamin A-supplemented mice in addition to mild colitis (Supplementary  Table  2).

(a)

(b)

Figure 8: (a) Colonic neoplasia induced by a single preinjection of azoxymethane (7.4 mg/kg) 14 days prior to intake of 1% DSS for 7 subsequent days (left, no neoplasia in a vitamin A-supplemented mouse, and right, neoplasia in a vitamin A-deficient mouse). (b) Invasive adenocarcinoma.

(a)

(b)

(c)

(d)

Figure 9: Representative dysplasia induced by a single preinjection of azoxymethane (7.4 mg/kg) 14 days prior to intake of 1% DSS for 7 subsequent days. (a) Depressed low grade dysplasia, (b) flat low grade dysplasia, (c) flat high grade dysplasia, and (d) elevated high grade dysplasia.

(a)

(b)

(c)

Figure 10: Significant difference of (a) appearing neoplasia including invasive carcinoma, high grade dysplasia, and low grade dysplasia, (b) total colitis score, and (c) colitis score of the distal segment between vitamin A-supplemented mice and vitamin A-deficient mice induced by a single preinjection of azoxymethane (7.4 mg/kg) 14 days prior to intake of 1% DSS for 7 subsequent days.

4. Discussion

Our results demonstrated that vitamin A inhibits development of DSS colitis and the subsequent development of colonic neoplasia and prolonged the recovery from colitis in a mouse model of DSS colitis.

Dietary vitamin A is essential for production of the precursor of tissue retinol, which participates in immunity and cell differentiation. First, in immunity, vitamin A deficiency causes a helper T cell imbalance with excess Th1 and insufficient Th2 function and a reduction in α4β7⁺ memory/activated T cell generation [23]. In contrast, retinoic acid, a vitamin A metabolite, enhances IL-22 production by γδ T cells in vitro and inhibits DSS-induced colitis [24]. We demonstrated an increase in CD11c⁺ dendritic cells in the colonic mucosa of vitamin A-deficient mice in line with results of both in vivo and in vitro studies using vitamin A-deficient rats performed by Dong et al. [4]. It can be suggested that this was a compensatory increase because vitamin A deficiency induces dendritic cell malfunction in the activation of T lymphocytes [25, 26] since vitamin A supplementation was shown to induce maturation of dendritic cells [4, 25, 27]. Further, vitamin A is necessary for generation of gut-homing IgA-secreting B cells by intestinal dendritic cells [28]. In the present study, a decrease in the ratio of IgA⁺ cells/IgG⁺ cells in the mucosa of the proximal segment of colon indicates an aspect of disorganization of mucosal immunity in vitamin A deficiency [23, 28, 29]. On the other hand, present experimental results were obtained in BALB/c mice, which had higher intestinal epithelial expression of retinaldehyde dehydrogenase 1 (RALDH1), leading to an increased activity to induce IgA class switching from B cells [24]. According to this, the results might be different in another strain with low expression of RALDH1, suggesting the possibility of differences in susceptibility of ulcerative colitis in humans. This remains to be clarified.

Second, in addition, hepatic stellate cells and intestinal subepithelial myofibroblasts participate in niche function for epithelial cell stem cells and progenitor cells in the liver and intestinal crypts, respectively [17, 19, 30–34]. Hepatic stellate cells need vitamin A-rich lipids to maintain their niche function. We found a decrease in subepithelial myofibroblasts in the crypt base of vitamin A-deficient mice as well as a reduction in cytoplasmic vitamin A lipids in subepithelial myofibroblasts. The decrease in α-SMA⁺ subepithelial myofibroblasts may indicate an alteration of the niche function for protection of colonic mucosal stem cells or progenitor cells based on the concept that α-SMA⁺ subepithelial myofibroblasts correspond to colonic stellate cells [17, 19, 34]. Thus, our findings might suggest that dysfunction of dendritic cells and subepithelial myofibroblasts caused by vitamin A deficiency accelerated DSS colitis, which resulted in the development of colorectal cancer in our DSS colitis mouse model.

Third, with regard to cell differentiation, it is well known that vitamin A and its metabolite, retinoids, play an important role [6, 35]. Retinoids perform effective chemoprevention against cancers in various organs and are used for differentiation therapy against acute promyelocytic leukemia [7]. Further, it was suggested clinically and experimentally that vitamin A deficiency promotes cancer development and progression [8, 9, 36–39]. Particularly, CYP26A1, the gene encoding the cytochrome P450 enzyme specifically involved in metabolic inactivation of retinoic acid, was highly expressed in breast cancers and showed oncogenic characteristics suggesting a link between intracellular retinoic acid status and tumorigenesis [15, 40, 41]. Our results that showed severe DSS colitis, prolonged recovery of DSS colitis, and the development of colonic tumors following DSS colitis in vitamin A-deficient mice are in line with previous reports of promotion of cancer development.

Although it is suggested that dietary and nutritional factors, including vitamin A, have an intimate relationship to development or exacerbation of inflammatory bowel diseases [42, 43], there are no any definite clinical indications of vitamin A administration. Our present basic research results may help us to know the possibility that vitamin A administration might inhibit colitis and subsequent cancer development, depending on unknown phenotypes of clinical cases of ulcerative colitis, if they are present. Further studies should be conducted to find the possible underlying mechanisms on inhibition of colitis and subsequent colonic neoplasia development by vitamin A supplementation.

5. Conclusion

Vitamin A inhibited development of DSS colitis and colorectal cancer in the DSS colitis mouse model. Therefore, vitamin A supplementation might help to improve diarrhea and enteritis in inflammatory bowel disease and could possibly inhibit insidious colonic inflammation and cancer development. These effects of vitamin A remain to be examined in a future study.

Ethical Approval

This experimental study using mice was approved by the Animal Experiment Committee, Kitasato University School of Medicine (2010-184).

Competing Interests

The authors declare that they have no competing interests.

Acknowledgments

This work was supported in part by a Grant-in-Aid for Japan Science and Technology Agency (no. 23659190).

References

R. H. Alkhouri, H. Hashmi, R. D. Baker, D. Gelfond, and S. S. Baker, “Vitamin and mineral status in patients with inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 56, no. 1, pp. 89–92, 2013.

A. Bousvaros, D. Zurakowski, C. Duggan et al., “Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity,” Journal of Pediatric Gastroenterology and Nutrition, vol. 26, no. 2, pp. 129–135, 1998.

O. P. Garcia, “Effect of vitamin A deficiency on the immune response in obesity,” Proceedings of the Nutrition Society, vol. 71, no. 2, pp. 290–297, 2012.

P. Dong, Y. Tao, Y. Yang, and W. Wang, “Expression of retinoic acid receptors in intestinal mucosa and the effect of vitamin A on mucosal immunity,” Nutrition, vol. 26, no. 7-8, pp. 740–745, 2010.

S. G. Kang, C. Wang, S. Matsumoto, and C. H. Kim, “High and low vitamin A therapies induce distinct FoxP3⁺ T-cell subsets and effectively control intestinal inflammation,” Gastroenterology, vol. 137, no. 4, pp. 1391–1402, 2009.

E. Batourina, S. Gim, N. Bello et al., “Vitamin A controls epithelial/mesenchymal interactions through Ret expression,” Nature Genetics, vol. 27, no. 1, pp. 74–78, 2001.

L. A. Hansen, C. C. Sigman, F. Andreola, S. A. Ross, G. J. Kelloff, and L. M. De Luca, “Retinoids in chemoprevention and differentiation therapy,” Carcinogenesis, vol. 21, no. 7, pp. 1271–1279, 2000.

A. L. French, L. M. Kirstein, L. S. Massad et al., “Association of vitamin A deficiency with cervical squamous intraepithelial lesions in human immunodeficiency virus-infected women,” Journal of Infectious Diseases, vol. 182, no. 4, pp. 1084–1089, 2000.

K. Li, J. Gao, X. Xiao, L. Chen, and L. Zhang, “The enhancing role of vitamin A deficiency on chemically induced nephroblastoma in rats,” Journal of Pediatric Surgery, vol. 40, no. 12, pp. 1951–1956, 2005.

E. Sonneveld, C. E. van den Brink, B.-J. M. van der Leede et al., “Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells,” Cell Growth and Differentiation, vol. 9, no. 8, pp. 629–637, 1998.

J. Van Heusden, W. Wouters, F. C. S. Ramaekers et al., “The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells,” British Journal of Cancer, vol. 77, no. 8, pp. 1229–1235, 1998.

D. N. Shelton, I. T. Sandoval, A. Eisinger et al., “Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development,” Cancer Research, vol. 66, no. 15, pp. 7571–7577, 2006.

C.-L. Chang, E. Hong, P. Lao-Sirieix, and R. C. Fitzgerald, “A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma,” Oncogene, vol. 27, no. 21, pp. 2951–2960, 2008.

M. Osanai and M. Petkovich, “Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death,” Molecular Pharmacology, vol. 67, no. 5, pp. 1808–1817, 2005.

M. Osanai, N. Sawada, and G.-H. Lee, “Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1,” Oncogene, vol. 29, no. 8, pp. 1135–1144, 2010.

R. C. Heine-Bröring, R. M. Winkels, J. M. S. Renkema et al., “Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies,” International Journal of Cancer, vol. 136, no. 10, pp. 2388–2401, 2015.

I. Okayasu, T. Yoshida, T. Mikami et al., “Mucosal remodeling in long-standing ulcerative colitis with colorectal neoplasia: significant alterations of NCAM⁺ or α-SMA⁺ subepithelial myofibroblasts and interstitial cells,” Pathology International, vol. 59, no. 10, pp. 701–711, 2009.

N. Lahar, N. Y. Lei, J. Wang et al., “Intestinal subepithelial myofibroblasts support in vitro and in vivo growth of human small intestinal epithelium,” PLoS ONE, vol. 6, no. 11, Article ID e26898, 2011.

I. Okayasu, T. Mikami, T. Yoshida et al., “Cytoglobin expression of rectal subepithelial myofibroblasts: significant alterations of cytoglobin⁺ stromal cells in long-standing ulcerative colitis,” Histology and Histopatholology, vol. 26, no. 6, pp. 679–688, 2011.

I. Okayasu, “Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence,” Pathology International, vol. 62, no. 6, pp. 368–380, 2012.

I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990.

I. Okayasu, T. Ohkusa, K. Kajiura, J. Kanno, and S. Sakamoto, “Promotion of colorectal neoplasia in experimental murine ulcerative colitis,” Gut, vol. 39, no. 1, pp. 87–92, 1996.

M. Iwata, A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S.-Y. Song, “Retinoic acid imprints gut-homing specificity on T cells,” Immunity, vol. 21, no. 4, pp. 527–538, 2004.

G. Goverse, B. J. Olivier, R. Molenaar et al., “Vitamin A metabolism and mucosal immune function are distinct between BALB/c and C57BL/6 mice,” European Journal of Immunology, vol. 45, no. 1, pp. 89–100, 2015.

A. Yokota, H. Takeuchi, N. Maeda et al., “GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity,” International Immunology, vol. 21, no. 4, pp. 361–377, 2009.

A. Yokota-Nakatsuma, H. Takeuchi, Y. Ohoka et al., “Retinoic acid prevents mesenteric lymph node dendritic cells from inducing IL-13-producing inflammatory Th2 cells,” Mucosal Immunology, vol. 7, no. 4, pp. 786–801, 2014.

M. Iwata, “Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking,” Seminars in Immunology, vol. 21, no. 1, pp. 8–13, 2009.

J. R. Mora, M. Iwata, B. Eksteen et al., “Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells,” Science, vol. 314, no. 5802, pp. 1157–1160, 2006.

J. L. Bjersing, E. Telemo, U. Dahlgren, and L. Å. Hanson, “Loss of ileal IgA⁺ plasma cells and of CD4⁺ lymphocytes in ileal Peyer's patches of vitamin A deficient rats,” Clinical and Experimental Immunology, vol. 130, no. 3, pp. 404–408, 2002.

T.-H. Yen and N. A. Wright, “The gastrointestinal tract stem cell niche,” Stem Cell Reviews, vol. 2, no. 3, pp. 203–212, 2006.

C. Kosinski, V. S. W. Li, A. S. Y. Chan et al., “Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15418–15423, 2007.

I. Sawitza, C. Kordes, S. Reister, and D. Häussinger, “The niche of stellate cells within rat liver,” Hepatology, vol. 50, no. 5, pp. 1617–1624, 2009.

C. Kordes, I. Sawitza, and D. Häussinger, “Hepatic and pancreatic stellate cells in focus,” Biological Chemistry, vol. 390, no. 10, pp. 1003–1012, 2009.

M. Plateroti, D. C. Rubin, I. Duluc et al., “Subepithelial fibroblast cell lines from different levels of gut axis display regional characteristics,” The American Journal of Physiology, vol. 274, no. 5, part 1, pp. G945–G954, 1998.

A. Janesick, S. C. Wu, and B. Blumberg, “Retinoic acid signaling and neuronal differentiation,” Cellular and Molecular Life Sciences, vol. 72, no. 8, pp. 1559–1576, 2015.

A. Bernstein and B. Harris, “The relationship of dietary and serum vitamin A to the occurrence of cervical intraepithelial neoplasia in sexually active women,” American Journal of Obstetrics and Gynecology, vol. 148, no. 3, pp. 309–312, 1984.

P. A. Stehr, M. F. Gloninger, L. H. Kuller, G. M. Marsh, E. P. Radford, and G. B. Weinberg, “Dietary vitamin A deficiencies and stomach cancer,” American Journal of Epidemiology, vol. 121, no. 1, pp. 65–70, 1985.

C.-P. Zou, J. L. Clifford, X.-C. Xu et al., “Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines,” Cancer Research, vol. 54, no. 20, pp. 5479–5487, 1994.

L. A. Hansen, D. Brown, V. Virador et al., “A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis,” Cancer Research, vol. 63, no. 17, pp. 5257–5265, 2003.

M. Osanai and G.-H. Lee, “Enhanced expression of retinoic acid-metabolizing enzyme CYP26A1 in sunlight-damaged human skin,” Medical Molecular Morphology, vol. 44, no. 4, pp. 200–206, 2011.

M. Osanai and G.-H. Lee, “Increased expression of the retinoic acid-metabolizing enzyme CYP26A1 during the progression of cervical squamous neoplasia and head and neck cancer,” BMC Research Notes, vol. 7, article 697, 2014.

A. Lan, F. Blachier, R. Benamouzig et al., “Mucosal healing in inflammatory bowel diseases: is there a place for nutritional supplementation?” Inflammatory Bowel Diseases, vol. 21, no. 1, pp. 198–207, 2015.

D. Owczarek, T. Rodacki, R. Domagala-Rodacka et al., “Diet and nutritional factors in inflammatory bowel diseases,” World Journal of Gastroenterology, vol. 22, no. 3, pp. 895–905, 2016.